pCMV14-3X-Flag-SARS-CoV-2 S Citations (13)
Originally described in: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z, Mu Z, Chen X, Chen J, Hu K, Jin Q, Wang J, Qian Z Nat Commun. 2020 Mar 27;11(1):1620. doi: 10.1038/s41467-020-15562-9. PubMed Journal
Articles Citing pCMV14-3X-Flag-SARS-CoV-2 S
| Articles |
|---|
| Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol. Condor Capcha JM, Lambert G, Dykxhoorn DM, Salerno AG, Hare JM, Whitt MA, Pahwa S, Jayaweera DT, Shehadeh LA. Front Cardiovasc Med. 2021 Jan 15;7:618651. doi: 10.3389/fcvm.2020.618651. eCollection 2020. PubMed |
| Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile. Beltran-Pavez C, Riquelme-Barrios S, Oyarzun-Arrau A, Gaete-Argel A, Gonzalez-Stegmaier R, Cereceda-Solis K, Aguirre A, Travisany D, Palma-Vejares R, Barriga GP, Gaggero A, Martinez-Valdebenito C, Corre NL, Ferres M, Balcells ME, Fernandez J, Ramirez E, Villarroel F, Valiente-Echeverria F, Soto-Rifo R. Sci Adv. 2021 Feb 12;7(7). pii: 7/7/eabe6855. doi: 10.1126/sciadv.abe6855. Print 2021 Feb. PubMed |
| A variant in TMPRSS2 is associated with decreased disease severity in COVID-19. Ravikanth V, Sasikala M, Naveen V, Latha SS, Parsa KVL, Vijayasarathy K, Amanchy R, Avanthi S, Govardhan B, Rakesh K, Kumari DS, Srikaran B, Rao GV, Reddy DN. Meta Gene. 2021 Sep;29:100930. doi: 10.1016/j.mgene.2021.100930. Epub 2021 May 28. PubMed |
| Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model. Shrivastava T, Singh B, Rizvi ZA, Verma R, Goswami S, Vishwakarma P, Jakhar K, Sonar S, Mani S, Bhattacharyya S, Awasthi A, Surjit M. Front Immunol. 2021 May 24;12:641447. doi: 10.3389/fimmu.2021.641447. eCollection 2021. PubMed |
| Seroprevalence of SARS-CoV-2 antibodies among rural healthcare workers. Neises JZ, Hossain MS, Sultana R, Wanniarachchi KN, Wollman JW, Nelson E, Specker BL, Hoppe AD, Lawson SR, Thiex NW. J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27224. PubMed |
| Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19. Shin J, Toyoda S, Nishitani S, Fukuhara A, Kita S, Otsuki M, Shimomura I. Diabetes. 2021 Dec;70(12):2745-2755. doi: 10.2337/db20-1094. Epub 2021 Oct 6. PubMed |
| A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo. Hanke L, Das H, Sheward DJ, Perez Vidakovics L, Urgard E, Moliner-Morro A, Kim C, Karl V, Pankow A, Smith NL, Porebski B, Fernandez-Capetillo O, Sezgin E, Pedersen GK, Coquet JM, Hallberg BM, Murrell B, McInerney GM. Nat Commun. 2022 Jan 10;13(1):155. doi: 10.1038/s41467-021-27610-z. PubMed |
| A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice. Coria LM, Saposnik LM, Pueblas Castro C, Castro EF, Bruno LA, Stone WB, Perez PS, Darriba ML, Chemes LB, Alcain J, Mazzitelli I, Varese A, Salvatori M, Auguste AJ, Alvarez DE, Pasquevich KA, Cassataro J. Front Immunol. 2022 Feb 28;13:844837. doi: 10.3389/fimmu.2022.844837. eCollection 2022. PubMed |
| Serum extracellular vesicles profiling is associated with COVID-19 progression and immune responses. Yim KHW, Borgoni S, Chahwan R. J Extracell Biol. 2022 Apr;1(4):e37. doi: 10.1002/jex2.37. Epub 2022 Apr 20. PubMed |
| Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor. Fonnesu R, Thunuguntla VBSC, Veeramachaneni GK, Bondili JS, La Rocca V, Filipponi C, Spezia PG, Sidoti M, Plicanti E, Quaranta P, Freer G, Pistello M, Mathai ML, Lai M. Viruses. 2022 May 17;14(5). pii: v14051080. doi: 10.3390/v14051080. PubMed |
| SARS-CoV-2 pseudotyped virus persists on the surface of multiple produce but can be inactivated with gaseous ozone. Mortazavi M, Bains A, Afsah-Hejri L, Ehsani R, LiWang PJ. Heliyon. 2022 Aug;8(8):e10280. doi: 10.1016/j.heliyon.2022.e10280. Epub 2022 Aug 15. PubMed |
| An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension. Fuchs E, Rudnik-Jansen I, Dinesen A, Selnihhin D, Mandrup OA, Thiam K, Kjems J, Pedersen FS, Howard KA. Acta Biomater. 2022 Nov;153:411-418. doi: 10.1016/j.actbio.2022.09.048. Epub 2022 Sep 24. PubMed |
| Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression. Bhullar KS, Nael MA, Elokely KM, Drews SJ, Wu J. Pharmaceutics. 2022 Sep 26;14(10):2045. doi: 10.3390/pharmaceutics14102045. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.